Sooner Clinical Research | Oklahoma City, OK

Research site

(Unclaimed)

Location

5929 N. May Avenue, Suite 401, Oklahoma City, Oklahoma, United States of America

Site insights

Top conditions

Top treatments

Cariprazine

Rapastinel

Pregabalin

SPD489

Dapagliflozin

Balsalazide Disodium

Eslicarbazepine Acetate

BMS-512148

Lyrica

Aticaprant

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

7 of 58 total trials

A Clinical Study That Will Measure How Well SEP-363856 Works and How Safe it is in Adults With Generalized Anxiety Disorder

A clinical study that will meaure how well SEP-363856 works and how safe it is in adults with Generalized Anixety Disorder. This study will be accept...

Enrolling

Generalized Anxiety Disorder

Drug: Placebo

Drug: SEP-363856

A Study of Aticaprant in Adult and Elderly Participants With Major Depressive Disorder (MDD) (VENTURA-LT)

The purpose of this study is to assess the long-term safety and tolerability of aticaprant administered as adjunctive therapy to a current antidepres...

Enrolling

Depressive Disorder, Major

Drug: Aticaprant

A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder. (3112 Ped BPD)

Bipolar disorder is a severe chronic mood disorder that affects up to 4% of the adult population and 1.8% of the pediatric population in the United S...

Enrolling

Bipolar I Disorder

Depression

Drug: Placebo

Drug: Cariprazine

A Study to Test Different Doses of BI 1569912 in People With Depression

This study is open to adults between 18 and 65 years of age with a type of depression called major depressive disorder. The purpose of the study is t...

Enrolling

Depressive Disorder, Major

Drug: Placebo matching BI 1569912

Drug: BI 1569912

A Study to Test Different Doses of BI 1569912 in People With Depression Who Take Anti-depressive Medicine

This study is open to adults between 18 and 65 with a type of depression (major depressive disorder) for whom previous treatments for depression did...

Active, not recruiting

Depressive Disorder, Major

Drug: BI 1569912

Drug: Placebo

GATE-251 or Placebo for the Reduction of Symptoms of Major Depressive Disorder

The goal of this clinical trial is to learn if GATE-251 works to treat depression in adults. It will also learn about the safety of GATE-251. The mai...

Enrolling

Major Depressive Disorder

Drug: Zelquistinel

Study of Oral ABBV-932 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Bipolar I or II Disorder (CANTO)

Bipolar disorder is a severe chronic mood disorder that affects up to 4% of the adult population in the United States. This study will assess how saf...

Enrolling

Bipolar II Disorder

Bipolar I Disorder

Drug: Placebo for ABBV-932

Drug: ABBV-932